Indian generics maker Ranbaxy Laboratories says it's set to plunk down more than half a million dollars on new healthcare facilities in the Punjab area of India, including hospitals and medical institutes.
The company already has proposed establishing a special tax zone in Mohali, Punjab, where it would invest $65 million in production facilities. There, it plans to ramp up manufacturing, churning out 10 million tablets over the next two years.
- here's the report [1] from India's Economic Times
Related Articles:
Indian court spurns Novartis on patent challenge. Report [2]
India's biotech future is bright. Report [3]
India ramps up biotech funding. Report [4]
Links:
[1] http://economictimes.indiatimes.com/Ranbaxy_to_invest_500-600_mn_in_Punjab/articleshow/2369376.cms
[2] http://www.fiercepharma.com/story/indian-court-spurns-novartis-patent-challenge/2007-08-06
[3] http://www.fiercebiotech.com/story/bangalore-bio-india-s-biotech-future-is-bright/2007-06-08
[4] http://www.fiercebiotech.com/story/india-ramps-up-biotech-funding/2006-11-01